Randomized Controlled Trial of Lifestyle Interventions for the Prevention of Diabetes in US Home Visiting Programs
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 978
- 试验地点
- 6
- 主要终点
- Diabetes/Pre-Diabetes
研究概览
简要总结
The study is examining the health effects of gestational diabetes mellitus (GDM) intervention and medically tailored meals within home visiting. A large study is proposed that will include nearly a thousand pregnant or recently pregnant adults with recent GDM and who are from different regions and backgrounds. Two treatment approaches are compared, and both are in home visiting. One treatment group is receiving enhanced lifestyle support for GDM along with meals, and the other is receiving just the enhanced lifestyle support. The study will examine whether these interventions help reduce diabetes and pre-diabetes through 12 months postpartum, as well as other health factors like weight and blood pressure.
详细描述
Gestational diabetes mellitus (GDM) is rapidly rising in prevalence and has been linked with several short and long-term adverse maternal health outcomes, including type 2 diabetes (T2DM) and cardiovascular disease. The postpartum year is a time of heightened risk, and 32-46% of people with GDM develop type 2 diabetes (T2DM) or Pre-Diabetes (PreDM) during the postpartum year. To prevent maternal diabetes, US guidelines recommend behavioral counseling to promote healthy eating, activity, and weight, but dissemination channels have been lacking. Evidence-based home visiting programs, with their well-established infrastructure in every state and focus on maternal and child health, are a promising platform through which the recommended behavioral interventions could reach people with GDM and reduce health disparities. Effective GDM intervention within home visiting needs to be potent, build on existing content, and remain brief, so as not to displace other evidence-based content. Integrating referral to medically tailored meals (MtMs) is a Food is Medicine strategy that may prevent and mitigate maternal diabetes in home visiting. Access to MtMs has been expanding rapidly in the US, with 10 states currently having and 5 states pending Medicaid Service waivers that offer coverage for MtMs. Systematic reviews have found that providing MtMs allows patients to experience significantly better glucose and weight management, improved food insecurity and dietary quality, and greater treatment satisfaction. MtMs also benefit health systems, insurers, and governments through reduced costs and fewer hospitalizations and emergency department visits. However, national calls and systematic reviews have identified a major evidence gap and the need for adequately powered effectiveness trials to determine whether MtMs are effective in treating and preventing maternal diabetes. For MtMs to continue as a treatment approach for GDM, compelling evidence is needed that they work and for whom and in what context. The primary aim of this study is to evaluate the 12-month incidence T2DM/PreDM in people with GDM who receive GDM Enhanced + Meals vs. GDM Enhanced Only within home visiting. A robust implementation process evaluation will inform ensure successful sustainment and reach for diverse pregnant and postpartum people with GDM. A Hybrid Type 1 effectiveness-implementation trial is proposed. The study will recruit 978 perinatal, English or Spanish-speaking adults nationwide from three clinical centers serving the West, Midwest/South, and East regions. Home visiting clients (35% Black; 40% Hispanic) with recent GDM diagnosis and will be randomized within site and home visiting agency to one of two treatment arms: GDM enhanced lifestyle intervention plus MtMs (GDM Enhanced + Meals) or GDM Enhanced Only. The primary study aim is to evaluate the 12-month incidence of T2DM/PreDM. Secondary aims will examine treatment group differences in health factors (weight, blood pressure) and client-centered outcomes (diet quality, physical activity, home food environment, food security, quality of life, treatment satisfaction, self-efficacy, mood) at 3, 6, and 12 months postpartum. Key moderators (Black/White race, Hispanic/Non-Hispanic ethnicity, food security), and mediators (changes in weight, dietary quality, physical activity, and the home food environment) will be identified. The RE-AIM framework will guide an implementation process evaluation to plan for successful delivery and sustainment of the interventions. Findings from this from large scale, adequately powered trial of MtMs for maternal health will fill a major gap in the literature. If the MTM approach is found effective, there will be strong justification to bolster access (at state level) and referrals (within home visiting) to MtMs. Findings will inform tailored strategies to ensure successful sustainment in home visiting and reach for diverse pregnant and postpartum people with GDM.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Currently in home visiting
- •Pregnant or < 3 months (13 weeks) postpartum
- •Gestational Diabetes Mellitus diagnosis in most recent pregnancy (based on self-report)
- •Aged 18 years or older
- •English- or Spanish-speaking.
- •Not currently being given medically tailored meals
- •Willing to receive randomization to either group
排除标准
- •Pre-existing diabetes (based on self-report)
研究组 & 干预措施
Usual Home Visiting plus GDM Enhanced
This group receives usual home visitation plus GDM Enhanced intervention.
干预措施: GDM Enhanced (Behavioral)
Usual HV + GDM Enhanced + Meals
This group will receive usual home visitation plus GDM Enhanced plus medically tailored meals.
干预措施: GDM Enhanced (Behavioral)
Usual HV + GDM Enhanced + Meals
This group will receive usual home visitation plus GDM Enhanced plus medically tailored meals.
干预措施: Meals (Behavioral)
结局指标
主要结局
Diabetes/Pre-Diabetes
时间窗: From enrollment to 12 months postpartum
The Primary Outcome Measure in this study is a categorical outcome of glucose tolerance (i.e., healthy glucose tolerance vs. type 2 diabetes/pre-diabetes) at 12 months postpartum. The test will be conducted at CLIA-certified lab. A 2-hour oral glucose tolerance test (OGTT) will characterize people into one of two categories: 1) healthy glucose tolerance; or 2) type 2 diabetes (2-hour post 75g load glucose level of 200 mg/dL or greater) or pre-diabetes (a 2-hour post 75g load glucose level of 140 to 199 mg/d).
次要结局
- HbA1c concentration(From enrollment to 3, 6, and 12 months postpartum)
- Systolic blood pressure(From enrollment to 3, 6, and 12 months postpartum)
- Diastolic blood pressure(From enrollment to 3, 6, and 12 months postpartum)
- Body weight(From enrollment to 3, 6, and 12 months postpartum)
- Child zBMI(From 3 months to 6 and 12 months)
- Diet quality(From enrollment to 3, 6, and 12 months postpartum)
- Metabolic equivalent task minutes per week of moderate-to-vigorous physical activity(From enrollment to 3, 6, and 12 months postpartum)
- Home Food Environment(From enrollment to 3, 6, and 12 months postpartum)
- Food Security(From enrollment to 3, 6, and 12 months postpartum)
- Global Physical Health(From enrollment to 3, 6, and 12 months postpartum)
- Global Mental Health(From enrollment to 3, 6, and 12 months postpartum)
- Nutrition Self-Efficacy(From enrollment to 3, 6, and 12 months postpartum)
- Center for Epidemiologic Studies Depression Scale(From enrollment to 3, 6, and 12 months postpartum)
- Barriers to Healthy Eating(From enrollment to 3, 6, and 12 months postpartum)
研究者
Suzanne Phelan
Professor
California Polytechnic State University-San Luis Obispo
